The diagnosis is based on clinical findings, serology, imaging, and confirmation by tissue biopsy whenever feasible. GPA is typically associated with cytoplasmic ANCA (c-ANCA) antibodies targeting proteinase 3 in 60-95% of patients [3]. The gene discussed is PRTN3; the disease is granulomatosis with polyangiitis.